Venetoclax resistance involves reduced mitochondrial priming and changes in BCL-2 family protein expression. ow.ly/tsqH50SXIFb #lymphoidneoplasia #immunobiologyandimmunotherapy

What an honor to write this commentary on Zaimoku et al. 👉10.1111/bjh.19712. together with Simona Pagliuca & Alberto Cardoso M. Lima, PhD British Journal of Haematology 👉onlinelibrary.wiley.com/doi/10.1111/bj…

What an honor to collaborate with Carmelo Gurnari and Simona Pagliuca.... You are roĺe models and I appreciate the opportunity to learn from your outstanding expertise on this amazing topic!

I am safe🏃‍♂️🏃‍♂️🏃‍♂️🤩

“Despite the strong evidence demonstrating the importance of sleep, many people fall short of sleep health targets.” 🛏 Learn more in a new review by Drs. Dr. Rebecca Robbins (PhD) and Stuart Quan: eviden.cc/4fc7hrm Harvard Medical School Division of Sleep Medicine #SleepMedicine

Thanks to Viktoria Blumenberg and Dr Marcela Maus from Mass General Cancer Center for this kind commentary in Nature Medicine on our recent meta-analysis on CAR-T related NRM! Next steps: risk mitigation strategies for infections + deeper understanding of ICAHT mechanisms. Check it out 👇

It’s almost here!!! See you all tomorrow in #Barcelona!!! #ITC24 So exciting!!! The EBMT EBMT_Cellular_Therapy The EBMT Trainee Committee EBMT Nurses

TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes? | Blood | American Society of Hematology ashpublications.org/blood/article/…

Good morning and welcome to #ITCTC24! 👏 Get ready for an exciting 3-day deep dive into hematopoietic progenitor transplantation, innovative #CellTherapy strategies, and groundbreaking #GeneTherapy! ☕ Grab your coffee, pen, and notebook—we're about to begin! 🚀 #HCT #transplant

Brilliant presentation Carmelo Gurnari on Germline predisposition at this year's #ITCTC24 The EBMT The EBMT Trainee Committee : Germline predisposition refers to inherited genetic mutations that increase the risk of diseases, including blood cancers. In hematology, identifying these

Case on CART for Anti Jo1 Antisynthetase Syndrome presented at #ITCTC24 The EBMT by very own The EBMT Trainee Committee johannarichter: **Anti-Jo1 antisynthetase syndrome** is an autoimmune condition characterized by the presence of anti-Jo1 antibodies, which target tRNA synthetase. It

Poster walk under insanely beautiful conditions #ITCTC24 The EBMT The EBMT Trainee Committee Krzysztof Kałwak

Moving from myeloid to lymphoid #ITCTC24 starting with a differentiated talk from Meral Beksac on transplant in myeloma and achievements over the years #mmsm The EBMT The EBMT Trainee Committee

#ITCTC24 is moving towards cellular therapies applications and now is the time of MM with Nico Gagelmann detailing how to implement CAR-T in this setting: Who? When? How? The EBMT Trainee Committee The EBMT EBMT_Cellular_Therapy

Back to back in lymphoid malignancies at #ITCTC24 Indications and management of CAR-T cells in lymphomas by Alberto Mussetti MD The EBMT The EBMT Trainee Committee EBMT_Cellular_Therapy Anna Sureda

Keynote speakers lectures at #ITCTC24 dedicated to autoimmune disease : raffaellagreco on CAR-T cells and Tobias Alexander on autologous HCT. The EBMT Trainee Committee The EBMT EBMT_Cellular_Therapy

Strong together Claire Horgan 🙏❤️🙏 Wonderful #ITCTC24, thanks The EBMT The EBMT Trainee Committee for making this unique learning experience for adults and pediatrics happen!

🎉 Enhorabuena a la Dra Maria Queralt Salas y al resto de investigadores del grupo de trabajo de Complicaciones No Infecciosas del GETH por su reciente publicación abordando los retos del manejo de los efectos adversos cardíacos tras #TPH con #PTCy 👉 ashpublications.org/bloodadvances/…

NEW learning module in The EBMT Trainee Committee Chimera platform, FREE online platform on all basics cellular therapy. Amazing project developed as grassroots from trainees for trainees. Go register for FREE and everyone can join + develop a learning module! Thanks all contributors🙏